CSI Market
Sign In | Register

Morphosys Ag (MOR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MOR Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Morphosys Ag manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
0 0 0 (Dec 31 2022)
Assets
Cash And Cash Equivalents177.52
Cash & Short-term Investments177.00
Inventories69.52
Other Current Assets664.67
Total Current Assets911.70
Equipment/Property/Plant Net4.36
Goodwill net383.37
Other Assets, Noncurrent970.04
Total Assets2,269.47
Liabilities
Short-term Debt273.30
Other Liabilities, Current22.72
Total Current Liabilities296.03
Total Long-term Debt0.00
Noncurrent Provisions1,918.51
Total Liabilities2,214.53
Stockholders' Equity
Other Equity54.94
Common Stockholder's Equity54.94
Total Stockholder's Equity54.94
Liabilities & Stockholder's Equity2,241.51
4 historic quarters locked

Sign in to unlock the full Morphosys Ag balance sheet history.

Sign In Create Free Account

About Morphosys Ag Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20231231)
  • Filed with the SEC: March 13, 2024
  • Source: mor-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-010887

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.